Jennifer Correa Riera

Download Vcard        jcorrea@fuerstlaw.com   305.350.5690

Jennifer Correa Riera is an attorney with Fuerst Ittleman David & Joseph, PL. She primarily practices in the areas of tax, tax litigation, and anti-money laundering. Throughout her career, Ms. Correa Riera has assisted numerous clients with regulatory and legal compliance issues involving the Internal Revenue Service (IRS or Service), the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Financial Crimes Enforcement Network (FinCEN), the Office of Foreign Asset Control (OFAC), and other federal and state agencies. Learn More

Overview

Jennifer Correa Riera is an attorney with Fuerst Ittleman David & Joseph, PL. She primarily practices in the areas of tax, tax litigation, and anti-money laundering. Throughout her career, Ms. Correa Riera has assisted numerous clients with regulatory and legal compliance issues involving the Internal Revenue Service (IRS or Service), the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Financial Crimes Enforcement Network (FinCEN), the Office of Foreign Asset Control (OFAC), and other federal and state agencies.

While practicing with Fuerst Ittleman David & Joseph, PL’s tax and tax litigation group, Ms.
Correa Riera has represented several clients involved in individual, corporate, and TEFRA partnership audits before the IRS. Additionally, Ms. Correa Riera has represented a number of clients involved in employment tax audits and corporate officers who have been assessed responsible person penalties under section 6672 of the Internal Revenue Code.
Ms. Correa Riera has also filed numerous protests and responses to 30–day Letters,
effectively communicating the client’s position and objections to the Revenue Agent’s audit findings to the IRS Office of Appeals.

Ms. Correa Riera has also assisted clients undergoing IRS collections and successfully stopped the IRS from levying financial accounts belonging to individuals, partnerships, corporations, and limited liability companies. She has negotiated Offers in Compromise and payment agreements with the Service on behalf of, and to the favor of, client taxpayers.

Additionally, Ms. Correa Riera has helped clients with undisclosed foreign financial accounts participate in the IRS’s various offshore voluntary disclosure amnesty programs and has advised them of their requirement to file Forms TD 90-22.1, “Report of Foreign Bank and Financial Accounts (FBAR)” and report income generated from these accounts on their individual tax returns. Ms. Correa Riera has also drafted and filed a number of petitions to the Tax Court contesting several multi-million dollar Statutory Notices of Deficiency as well as lawsuits filed in the U.S. District Court for the Southern District of Florida and appeals filed in the U.S. Court of Appeals for the Eleventh Circuit.

In addition to tax and tax litigation experience, Ms. Correa Riera is well versed in anti-money laundering regulations and the Bank Secrecy Act (BSA). Ms. Correa Riera has represented several clients in matters involving ant-money laundering (AML) programs and compliance, including “Know Your Customer” (KYC) reporting requirements and filing requirements for Currency Transaction Reports (CTRs or FinCEN Form 104) and Suspicious Activity Reports (SARs). She has also represented clients prosecuted for operating unregistered money transmitting businesses and servicing individuals appearing on OFAC’s Specially Designated Nationals (SDN) List.

Ms. Correa Riera has done additional work in the areas of food and drug, corporate law, and international law.

Prior to joining Fuerst Ittleman David & Joseph, PL, Ms. Correa Riera was a Certified Legal Intern with the Florida Office of Financial Regulation. While there, she was involved in the construction and development of Florida Statutes, Chapter 560, statutes describing the licensing and anti-money laundering program requirements for money transmitting businesses. Ms. Correa Riera also participated in investigations involving bank, mortgage, and securities fraud.

Credentials

Education 

  • University of Miami School of Law Coral Gables, Florida J.D.
  • Emory University, Atlanta, Georgia, B.A .

Admitted

  • United States Supreme Court Florida
  • United States Court of Appeals for the Federal Circuit
  • United States Court of Appeals for the District of Columbia Circuit
  • United States Court of Appeals for the Tenth Circuit
  • United States Court of Appeals for the Eighth Circuit
  • United States District Court for the Southern District of Florida
  • United States District Court for the District of Colorado
  • United States District Court for the Northern District of Illinois
  • United States Tax Court
  • United States Court of Federal Claims

Memberships

  • Association of Certified Anti-Money Laundering Specialists
  • National Money Transmitters Association
  • National Association of Criminal Defense Lawyers.

Publications

Speaking Engagements

  •  Presenter, “Banking Marijuana-Related Companies,” ACAMS & ACFE South Florida Chapter 2014 AML/Fraud Conference, Miami, Florida, November 7, 2014
  • Presenter, “Understanding Virtual Currencies,” IMTC World, Miami, Florida, October 7, 2014
  • Host, Moderator, Presenter: “Virtual Currencies & Alternative Payments Certification Course,” IMTC World, Miami, Florida, October 6, 2014
  • Panelist, “Bitcoin: Where Is It Going and What Should You and Your Clients Know,” Greater Miami Jewish Federation, Fall Seminar, Miami, Florida, September 19, 2014
  • Host, Moderator, Presenter, “Bitcoin Workshop,” IMTC USA, San Diego, CA, June 25, 2014
  • Panelist, “Understanding Mt. Gox,” Texas Bitcoin Conference, Austin, TX, March 5, 2014
  • Panelist, “Bitcoin and Regulation,” Texas Bitcoin Conference, Austin, TX, March 6, 2014
  • Presenter, “United States Regulation of Autologous Stem Cell Procedures,” Stemso, Freeport, Bahamas, February 20, 2014
  • Presenter, “United States Regulation of Autologous Stem Cell Procedures,” New York Stem Cell Summit, New York, NY, February 18, 2014
  • Presenter, “The Lay of the Land for Money Services Businesses,” National Money Transmitters Association, Industry Symposium for Legislative Action, Washington, DC, February 18, 2014
  • Panelist, “Shades of Gray: Collateral Consequences of Risky Promotional Activities: False Claims Act,” Food and Drug Law Institute (FDLI) Advertising & Promotion Conference, Washington, D.C., September 17, 2013
  • Presenter, “The Importance of Management in the Casino AML Infrastructure,” Florida Department of Business and Professional Regulation Anti-Money Laundering Conference, University of Miami, Coral Gables, FL, August 23, 2013
  • Panelist, “Are Regulations Keeping Pace with Payment Technologies and the Market?,” International Money Transfer Conference (Los Angeles), April 4, 2013
  • Panelist, “Are Stem Cells Drugs?,” New York Stem Cell Summit, New York, New York, February 18, 2013
  • Panelist, “Ethical Patient Recruitment and Marketing,” STEMSO International Stem Cell Society, Fort Lauderdale, Florida, February 6-8, 2013
  • Presenter, “FDA’s Regulation of Autologous Stem Cell Procedures,” STEMSO International Stem Cell Society, Fort Lauderdale, Florida, February 6-8, 2013
  • Presenter, “Purchasing Injectables: A Risk Analysis,” American Academy of Cosmetic Surgery, Annual Scientific Meeting (Las Vegas, Nevada), January 17, 2013; discussed in “Savings vs. Safety,” MedEsthetics Magazine, March/April 2013
  • Presenter, “Physicians’ Use of Autologous Stem Cell Procedures,” American Academy of Cosmetic Surgery, Annual Scientific Meeting (Las Vegas, Nevada), January 16, 2013
  • Presenter, “Autologous Stem Cell Procedures: Resolving the Disconnect between FDA and Medical Practitioners,” The Food & Drug Law Institute (FDLI), Washington, D.C., November 29, 2012
  • Panel Member: Autologous Stem Cell Therapies are Not Drugs: Houston Stem Cell Summit, October 27, 2012
  • Panel Member: A Federal Money Transmitting License: International Money Transfer Conference (Miami), October 25, 2012
  • Presenter, “How United States Law Affects Non-U.S. Financial Institutions,” International Money Transmitters Conference (Los Angeles), May 30 – June 1, 2012
  • Presenter, “Regulation of a Physician’s Use of Adipose Stem Cells,” Ninth Annual Symposium on Adipose Stem Cells and Clinical Applications of Adipose Tissue, International Federation for Adipose Therapeutics and Science (IFATS), November 4-6, 2011
  • Presenter,  “The Evolving Definition of Money Transmitting Business,” International Money Transmitters Conference (Los Angeles), April 13-15, 2011
  • Presenter, “How United States Law Affects Non-U.S. Financial Institutions,” International Money Transmitters Conference (Miami), October 17-19, 2010
  • Presenter, “The Defenders Tale: War Stories from the Field,” International Money Transmitters Conference (Miami), October 4-6, 2009 (available here)
  • Panel Member, “Legal Issues Impacting MSBs: Recent Developments,” International Money Transmitters Conference (Miami), September 22-23, 2008
  • Panel Member, “Ask the Experts: Money Transmitters and Money Laundering Prosecutions,” International Money Transmitters Conference (Miami), November 3-5, 2007
  • Presenter, “Money Laundering, Security and Business: What are the Implications,” Spain – United States Chamber of Commerce, June 28, 2007

Publications

  • Co-authored, “When the World Innovates But the Law Stands Still”, South Florida Legal Guide, Mid Year 2014.
  • Co-authored, Bitcoin Taxation: Understanding IRS Notice 2014-21,” Bitcoin Magazine, April 4, 2014
  • Co-authored, Marijuana Taxation Update: IRC § 280E — An Albatross For the Marijuana Industry,” Law360.com, March 19, 2014
  • Co-Author of Need for Regulatory Harmonization: How FDA and FTC’s Shared Jurisdiction Poses Problems for Labeling & Advertising Compliance, FCN Committee Newsletter (A.B.A. Section of Science & Technology Law: Food, Cosmetics and Nutraceuticals), Winter 2014, at 2, 8-11.
  • Hurdles in Accessing Banking Services,” South Florida Legal Guide, 2013 Financial Edition
  • Co-authored, “Chapter XII – FDA Enforcement Actions: Potential Consequences of Non-Compliance” in FDLI Primer FDA’s Regulation of Veterinary Drug Products, (2013).
  • Featured in, “Savings vs. Safety: The FDA is cracking down on physicians who purchase injectables from non-U.S. suppliers,” MedEsthetics Magazine, March-April, 2013
  • FDLI: Food and Drug Policy Forum: Enforcement Discretion: How Can FDA More Reasonably Regulate Autologous Stem Cell Procedures, Vol.2, Issue 24, December 26, 2012
  • Inside the Minds: Recent Developments in Food and Drug Law: Leading Lawyers on Dealing with Increased Enforcement, Keeping Up-to-Date with FDA Requirements, and Developing Compliance Practices, 2013 Edition: “The FDA’s Regulation of Autologous Stem Cell Therapies”
  • Forbes.com: “Cash Is King,” March 18, 2008